Last reviewed · How we verify
FORODESINE HYDROCHLORIDE
FORODESINE HYDROCHLORIDE is a drug. It is currently FDA-approved (first approved 2017).
Forodesine hydrochloride is a medication used to treat various types of leukemia and lymphoma, including T-cell leukemia, chronic lymphocytic leukemia, and lymphoma. It is administered as an infusion to patients with advanced disease.
At a glance
| Generic name | FORODESINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2017 |
Approved indications
Common side effects
Key clinical trials
- Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients (PHASE1, PHASE2)
- Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies (PHASE1)
- Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma (PHASE1)
- BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma (PHASE1, PHASE2)
- BCX-1777 in Treating Patients With Refractory Cancer (PHASE1)
- Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL) (PHASE2)
- Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens (PHASE2)
- Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FORODESINE HYDROCHLORIDE CI brief — competitive landscape report
- FORODESINE HYDROCHLORIDE updates RSS · CI watch RSS
Frequently asked questions about FORODESINE HYDROCHLORIDE
What is FORODESINE HYDROCHLORIDE?
When was FORODESINE HYDROCHLORIDE approved?
What development phase is FORODESINE HYDROCHLORIDE in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing